Eldon has over 30 years of biopharma commercial experience in companies ranging from early stage biotechs to full scale pharmaceutical companies across many therapeutic areas, including oncology. Prior to joining Celcuity, Eldon was Chief Commercial Officer at Eiger Biopharmaceuticals where he led the commercial planning and execution of several pipeline assets including the global launch of Zokinvy® for progeria and progeroid laminopathies. Before Eiger, Eldon was Chief Commercial Officer at Rigel Pharmaceuticals where he built the commercial organization from the ground up and successfully launched Tavalisse® for chronic immune thrombocytopenia. Eldon had previously served as Senior Vice President of Commercial Operations at Questcor Pharmaceuticals, where he built a large commercial team that generated over $1 billion in annual sales of Acthar®. Earlier in his career, Eldon held positions of increasing responsibility at companies such as Schering-Plough, ALZA, Chiron, and Connetics in strategic planning, marketing, sales, market research/analytics, and finance. Eldon has served as a member of the board of directors for Eiger BioPharmaceuticals, Promet Therapeutics, and the National Community Oncology Dispensing Association. Eldon holds a BS degree from Fairleigh Dickinson University and an MBA from Syracuse University.
Eldon Mayer
